Summary

The global Calming Aids for Dogs market size is predicted to grow from US$ 556 million in 2025 to US$ 838 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
Canine sedatives refer to a class of drugs specifically used for canines, which are intended to calm, soothe or reduce anxiety through drug effects. Such drugs are usually used in veterinary clinical practice to help dogs stay calm during surgery, examination, treatment or specific stressful situations (such as travel, thunderstorm phobia, separation anxiety, etc.), reduce tension, fear or aggressive behavior, thereby ensuring the smooth progress of medical operations or improving animal welfare.
The market for canine sedatives has shown a steady growth trend in recent years, mainly benefiting from the booming pet economy and the significant increase in pet owners' attention to pet health and welfare. With the acceleration of urbanization and the improvement of people's living standards, the number of pet-raising families is increasing. As one of the most common pets, dogs have increasingly diversified medical needs, especially the use of sedatives, including surgical anesthesia assistance, behavior correction, travel comfort, etc. Current market dynamics show that technological innovation is the key to driving the development of the industry. The research and development of new sedatives focuses on safer, more efficient, and low-side effect products, such as drugs based on natural ingredients or targeted mechanisms of action, to meet the market's demand for pet-friendly medical solutions. At the same time, the strengthening of regulatory supervision has prompted companies to pay more attention to product quality and compliance, while the expansion of online sales channels and the digital transformation of pet medical services have also brought new growth points to the dog sedative market. It is expected that in the next few years, with the continued expansion of the pet medical market and the deepening of consumer awareness, the dog sedative market will maintain steady growth and develop in a more professional and refined direction.
LP Information, Inc. (LPI) ' newest research report, the “Calming Aids for Dogs Industry Forecast” looks at past sales and reviews total world Calming Aids for Dogs sales in 2024, providing a comprehensive analysis by region and market sector of projected Calming Aids for Dogs sales for 2025 through 2031. With Calming Aids for Dogs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calming Aids for Dogs industry.
This Insight Report provides a comprehensive analysis of the global Calming Aids for Dogs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Calming Aids for Dogs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Calming Aids for Dogs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calming Aids for Dogs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calming Aids for Dogs.
This report presents a comprehensive overview, market shares, and growth opportunities of Calming Aids for Dogs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Calming Supplements
Pheromone Sprays
Calming Collars
Anxiety Vests
Segmentation by Application:
Household
Pet Hospitals and Clinics
Pet Shop
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
VetriScience
H&H Group
Vetoquinol
ThunderEase
Maxxidog
Heavenly Hounds
ElleVet Sciences
Wild One
FOMO Bones
Ark Naturals
Purina
Kradle
Zoetis
Pet Remedy
Ceva
Adaptil
Primo Pup
Penelope's Bloom
Extract Labs
Koi CBD
Elanco
Zatural
The Anxious Pet
This Dog's Life
NaturVet
King Kanine
Dr. Harvey’s
PetHonesty
Merck Animal Health
Boehringer Ingelheim
Shangrao Chunyu Technology
Shandong Youmi Le Health Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Calming Aids for Dogs market?
What factors are driving Calming Aids for Dogs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Calming Aids for Dogs market opportunities vary by end market size?
How does Calming Aids for Dogs break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Calming Aids for Dogs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Calming Aids for Dogs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Calming Aids for Dogs by Country/Region, 2020, 2024 & 2031
2.2 Calming Aids for Dogs Segment by Type
2.2.1 Calming Supplements
2.2.2 Pheromone Sprays
2.2.3 Calming Collars
2.2.4 Anxiety Vests
2.3 Calming Aids for Dogs Sales by Type
2.3.1 Global Calming Aids for Dogs Sales Market Share by Type (2020-2025)
2.3.2 Global Calming Aids for Dogs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Calming Aids for Dogs Sale Price by Type (2020-2025)
2.4 Calming Aids for Dogs Segment by Application
2.4.1 Household
2.4.2 Pet Hospitals and Clinics
2.4.3 Pet Shop
2.4.4 Others
2.5 Calming Aids for Dogs Sales by Application
2.5.1 Global Calming Aids for Dogs Sale Market Share by Application (2020-2025)
2.5.2 Global Calming Aids for Dogs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Calming Aids for Dogs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Calming Aids for Dogs Breakdown Data by Company
3.1.1 Global Calming Aids for Dogs Annual Sales by Company (2020-2025)
3.1.2 Global Calming Aids for Dogs Sales Market Share by Company (2020-2025)
3.2 Global Calming Aids for Dogs Annual Revenue by Company (2020-2025)
3.2.1 Global Calming Aids for Dogs Revenue by Company (2020-2025)
3.2.2 Global Calming Aids for Dogs Revenue Market Share by Company (2020-2025)
3.3 Global Calming Aids for Dogs Sale Price by Company
3.4 Key Manufacturers Calming Aids for Dogs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Calming Aids for Dogs Product Location Distribution
3.4.2 Players Calming Aids for Dogs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Calming Aids for Dogs by Geographic Region
4.1 World Historic Calming Aids for Dogs Market Size by Geographic Region (2020-2025)
4.1.1 Global Calming Aids for Dogs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Calming Aids for Dogs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Calming Aids for Dogs Market Size by Country/Region (2020-2025)
4.2.1 Global Calming Aids for Dogs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Calming Aids for Dogs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Calming Aids for Dogs Sales Growth
4.4 APAC Calming Aids for Dogs Sales Growth
4.5 Europe Calming Aids for Dogs Sales Growth
4.6 Middle East & Africa Calming Aids for Dogs Sales Growth
5 Americas
5.1 Americas Calming Aids for Dogs Sales by Country
5.1.1 Americas Calming Aids for Dogs Sales by Country (2020-2025)
5.1.2 Americas Calming Aids for Dogs Revenue by Country (2020-2025)
5.2 Americas Calming Aids for Dogs Sales by Type (2020-2025)
5.3 Americas Calming Aids for Dogs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Calming Aids for Dogs Sales by Region
6.1.1 APAC Calming Aids for Dogs Sales by Region (2020-2025)
6.1.2 APAC Calming Aids for Dogs Revenue by Region (2020-2025)
6.2 APAC Calming Aids for Dogs Sales by Type (2020-2025)
6.3 APAC Calming Aids for Dogs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Calming Aids for Dogs by Country
7.1.1 Europe Calming Aids for Dogs Sales by Country (2020-2025)
7.1.2 Europe Calming Aids for Dogs Revenue by Country (2020-2025)
7.2 Europe Calming Aids for Dogs Sales by Type (2020-2025)
7.3 Europe Calming Aids for Dogs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Calming Aids for Dogs by Country
8.1.1 Middle East & Africa Calming Aids for Dogs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Calming Aids for Dogs Revenue by Country (2020-2025)
8.2 Middle East & Africa Calming Aids for Dogs Sales by Type (2020-2025)
8.3 Middle East & Africa Calming Aids for Dogs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Calming Aids for Dogs
10.3 Manufacturing Process Analysis of Calming Aids for Dogs
10.4 Industry Chain Structure of Calming Aids for Dogs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Calming Aids for Dogs Distributors
11.3 Calming Aids for Dogs Customer
12 World Forecast Review for Calming Aids for Dogs by Geographic Region
12.1 Global Calming Aids for Dogs Market Size Forecast by Region
12.1.1 Global Calming Aids for Dogs Forecast by Region (2026-2031)
12.1.2 Global Calming Aids for Dogs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Calming Aids for Dogs Forecast by Type (2026-2031)
12.7 Global Calming Aids for Dogs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 VetriScience
13.1.1 VetriScience Company Information
13.1.2 VetriScience Calming Aids for Dogs Product Portfolios and Specifications
13.1.3 VetriScience Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 VetriScience Main Business Overview
13.1.5 VetriScience Latest Developments
13.2 H&H Group
13.2.1 H&H Group Company Information
13.2.2 H&H Group Calming Aids for Dogs Product Portfolios and Specifications
13.2.3 H&H Group Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 H&H Group Main Business Overview
13.2.5 H&H Group Latest Developments
13.3 Vetoquinol
13.3.1 Vetoquinol Company Information
13.3.2 Vetoquinol Calming Aids for Dogs Product Portfolios and Specifications
13.3.3 Vetoquinol Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vetoquinol Main Business Overview
13.3.5 Vetoquinol Latest Developments
13.4 ThunderEase
13.4.1 ThunderEase Company Information
13.4.2 ThunderEase Calming Aids for Dogs Product Portfolios and Specifications
13.4.3 ThunderEase Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ThunderEase Main Business Overview
13.4.5 ThunderEase Latest Developments
13.5 Maxxidog
13.5.1 Maxxidog Company Information
13.5.2 Maxxidog Calming Aids for Dogs Product Portfolios and Specifications
13.5.3 Maxxidog Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Maxxidog Main Business Overview
13.5.5 Maxxidog Latest Developments
13.6 Heavenly Hounds
13.6.1 Heavenly Hounds Company Information
13.6.2 Heavenly Hounds Calming Aids for Dogs Product Portfolios and Specifications
13.6.3 Heavenly Hounds Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Heavenly Hounds Main Business Overview
13.6.5 Heavenly Hounds Latest Developments
13.7 ElleVet Sciences
13.7.1 ElleVet Sciences Company Information
13.7.2 ElleVet Sciences Calming Aids for Dogs Product Portfolios and Specifications
13.7.3 ElleVet Sciences Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ElleVet Sciences Main Business Overview
13.7.5 ElleVet Sciences Latest Developments
13.8 Wild One
13.8.1 Wild One Company Information
13.8.2 Wild One Calming Aids for Dogs Product Portfolios and Specifications
13.8.3 Wild One Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Wild One Main Business Overview
13.8.5 Wild One Latest Developments
13.9 FOMO Bones
13.9.1 FOMO Bones Company Information
13.9.2 FOMO Bones Calming Aids for Dogs Product Portfolios and Specifications
13.9.3 FOMO Bones Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 FOMO Bones Main Business Overview
13.9.5 FOMO Bones Latest Developments
13.10 Ark Naturals
13.10.1 Ark Naturals Company Information
13.10.2 Ark Naturals Calming Aids for Dogs Product Portfolios and Specifications
13.10.3 Ark Naturals Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ark Naturals Main Business Overview
13.10.5 Ark Naturals Latest Developments
13.11 Purina
13.11.1 Purina Company Information
13.11.2 Purina Calming Aids for Dogs Product Portfolios and Specifications
13.11.3 Purina Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Purina Main Business Overview
13.11.5 Purina Latest Developments
13.12 Kradle
13.12.1 Kradle Company Information
13.12.2 Kradle Calming Aids for Dogs Product Portfolios and Specifications
13.12.3 Kradle Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kradle Main Business Overview
13.12.5 Kradle Latest Developments
13.13 Zoetis
13.13.1 Zoetis Company Information
13.13.2 Zoetis Calming Aids for Dogs Product Portfolios and Specifications
13.13.3 Zoetis Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zoetis Main Business Overview
13.13.5 Zoetis Latest Developments
13.14 Pet Remedy
13.14.1 Pet Remedy Company Information
13.14.2 Pet Remedy Calming Aids for Dogs Product Portfolios and Specifications
13.14.3 Pet Remedy Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Pet Remedy Main Business Overview
13.14.5 Pet Remedy Latest Developments
13.15 Ceva
13.15.1 Ceva Company Information
13.15.2 Ceva Calming Aids for Dogs Product Portfolios and Specifications
13.15.3 Ceva Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Ceva Main Business Overview
13.15.5 Ceva Latest Developments
13.16 Adaptil
13.16.1 Adaptil Company Information
13.16.2 Adaptil Calming Aids for Dogs Product Portfolios and Specifications
13.16.3 Adaptil Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Adaptil Main Business Overview
13.16.5 Adaptil Latest Developments
13.17 Primo Pup
13.17.1 Primo Pup Company Information
13.17.2 Primo Pup Calming Aids for Dogs Product Portfolios and Specifications
13.17.3 Primo Pup Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Primo Pup Main Business Overview
13.17.5 Primo Pup Latest Developments
13.18 Penelope's Bloom
13.18.1 Penelope's Bloom Company Information
13.18.2 Penelope's Bloom Calming Aids for Dogs Product Portfolios and Specifications
13.18.3 Penelope's Bloom Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Penelope's Bloom Main Business Overview
13.18.5 Penelope's Bloom Latest Developments
13.19 Extract Labs
13.19.1 Extract Labs Company Information
13.19.2 Extract Labs Calming Aids for Dogs Product Portfolios and Specifications
13.19.3 Extract Labs Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Extract Labs Main Business Overview
13.19.5 Extract Labs Latest Developments
13.20 Koi CBD
13.20.1 Koi CBD Company Information
13.20.2 Koi CBD Calming Aids for Dogs Product Portfolios and Specifications
13.20.3 Koi CBD Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Koi CBD Main Business Overview
13.20.5 Koi CBD Latest Developments
13.21 Elanco
13.21.1 Elanco Company Information
13.21.2 Elanco Calming Aids for Dogs Product Portfolios and Specifications
13.21.3 Elanco Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Elanco Main Business Overview
13.21.5 Elanco Latest Developments
13.22 Zatural
13.22.1 Zatural Company Information
13.22.2 Zatural Calming Aids for Dogs Product Portfolios and Specifications
13.22.3 Zatural Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Zatural Main Business Overview
13.22.5 Zatural Latest Developments
13.23 The Anxious Pet
13.23.1 The Anxious Pet Company Information
13.23.2 The Anxious Pet Calming Aids for Dogs Product Portfolios and Specifications
13.23.3 The Anxious Pet Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 The Anxious Pet Main Business Overview
13.23.5 The Anxious Pet Latest Developments
13.24 This Dog's Life
13.24.1 This Dog's Life Company Information
13.24.2 This Dog's Life Calming Aids for Dogs Product Portfolios and Specifications
13.24.3 This Dog's Life Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 This Dog's Life Main Business Overview
13.24.5 This Dog's Life Latest Developments
13.25 NaturVet
13.25.1 NaturVet Company Information
13.25.2 NaturVet Calming Aids for Dogs Product Portfolios and Specifications
13.25.3 NaturVet Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 NaturVet Main Business Overview
13.25.5 NaturVet Latest Developments
13.26 King Kanine
13.26.1 King Kanine Company Information
13.26.2 King Kanine Calming Aids for Dogs Product Portfolios and Specifications
13.26.3 King Kanine Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 King Kanine Main Business Overview
13.26.5 King Kanine Latest Developments
13.27 Dr. Harvey’s
13.27.1 Dr. Harvey’s Company Information
13.27.2 Dr. Harvey’s Calming Aids for Dogs Product Portfolios and Specifications
13.27.3 Dr. Harvey’s Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.27.4 Dr. Harvey’s Main Business Overview
13.27.5 Dr. Harvey’s Latest Developments
13.28 PetHonesty
13.28.1 PetHonesty Company Information
13.28.2 PetHonesty Calming Aids for Dogs Product Portfolios and Specifications
13.28.3 PetHonesty Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.28.4 PetHonesty Main Business Overview
13.28.5 PetHonesty Latest Developments
13.29 Merck Animal Health
13.29.1 Merck Animal Health Company Information
13.29.2 Merck Animal Health Calming Aids for Dogs Product Portfolios and Specifications
13.29.3 Merck Animal Health Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.29.4 Merck Animal Health Main Business Overview
13.29.5 Merck Animal Health Latest Developments
13.30 Boehringer Ingelheim
13.30.1 Boehringer Ingelheim Company Information
13.30.2 Boehringer Ingelheim Calming Aids for Dogs Product Portfolios and Specifications
13.30.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.30.4 Boehringer Ingelheim Main Business Overview
13.30.5 Boehringer Ingelheim Latest Developments
13.31 Shangrao Chunyu Technology
13.31.1 Shangrao Chunyu Technology Company Information
13.31.2 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolios and Specifications
13.31.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.31.4 Shangrao Chunyu Technology Main Business Overview
13.31.5 Shangrao Chunyu Technology Latest Developments
13.32 Shandong Youmi Le Health Technology
13.32.1 Shandong Youmi Le Health Technology Company Information
13.32.2 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolios and Specifications
13.32.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2020-2025)
13.32.4 Shandong Youmi Le Health Technology Main Business Overview
13.32.5 Shandong Youmi Le Health Technology Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Calming Aids for Dogs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Calming Aids for Dogs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Calming Supplements
Table 4. Major Players of Pheromone Sprays
Table 5. Major Players of Calming Collars
Table 6. Major Players of Anxiety Vests
Table 7. Global Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
Table 8. Global Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Table 9. Global Calming Aids for Dogs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Calming Aids for Dogs Revenue Market Share by Type (2020-2025)
Table 11. Global Calming Aids for Dogs Sale Price by Type (2020-2025) & (US$/Dose)
Table 12. Global Calming Aids for Dogs Sale by Application (2020-2025) & (K Dose)
Table 13. Global Calming Aids for Dogs Sale Market Share by Application (2020-2025)
Table 14. Global Calming Aids for Dogs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Calming Aids for Dogs Revenue Market Share by Application (2020-2025)
Table 16. Global Calming Aids for Dogs Sale Price by Application (2020-2025) & (US$/Dose)
Table 17. Global Calming Aids for Dogs Sales by Company (2020-2025) & (K Dose)
Table 18. Global Calming Aids for Dogs Sales Market Share by Company (2020-2025)
Table 19. Global Calming Aids for Dogs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Calming Aids for Dogs Revenue Market Share by Company (2020-2025)
Table 21. Global Calming Aids for Dogs Sale Price by Company (2020-2025) & (US$/Dose)
Table 22. Key Manufacturers Calming Aids for Dogs Producing Area Distribution and Sales Area
Table 23. Players Calming Aids for Dogs Products Offered
Table 24. Calming Aids for Dogs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Calming Aids for Dogs Sales by Geographic Region (2020-2025) & (K Dose)
Table 28. Global Calming Aids for Dogs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Calming Aids for Dogs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Calming Aids for Dogs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Calming Aids for Dogs Sales by Country/Region (2020-2025) & (K Dose)
Table 32. Global Calming Aids for Dogs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Calming Aids for Dogs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Calming Aids for Dogs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 36. Americas Calming Aids for Dogs Sales Market Share by Country (2020-2025)
Table 37. Americas Calming Aids for Dogs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
Table 39. Americas Calming Aids for Dogs Sales by Application (2020-2025) & (K Dose)
Table 40. APAC Calming Aids for Dogs Sales by Region (2020-2025) & (K Dose)
Table 41. APAC Calming Aids for Dogs Sales Market Share by Region (2020-2025)
Table 42. APAC Calming Aids for Dogs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
Table 44. APAC Calming Aids for Dogs Sales by Application (2020-2025) & (K Dose)
Table 45. Europe Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 46. Europe Calming Aids for Dogs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
Table 48. Europe Calming Aids for Dogs Sales by Application (2020-2025) & (K Dose)
Table 49. Middle East & Africa Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 50. Middle East & Africa Calming Aids for Dogs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
Table 52. Middle East & Africa Calming Aids for Dogs Sales by Application (2020-2025) & (K Dose)
Table 53. Key Market Drivers & Growth Opportunities of Calming Aids for Dogs
Table 54. Key Market Challenges & Risks of Calming Aids for Dogs
Table 55. Key Industry Trends of Calming Aids for Dogs
Table 56. Calming Aids for Dogs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Calming Aids for Dogs Distributors List
Table 59. Calming Aids for Dogs Customer List
Table 60. Global Calming Aids for Dogs Sales Forecast by Region (2026-2031) & (K Dose)
Table 61. Global Calming Aids for Dogs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Calming Aids for Dogs Sales Forecast by Country (2026-2031) & (K Dose)
Table 63. Americas Calming Aids for Dogs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Calming Aids for Dogs Sales Forecast by Region (2026-2031) & (K Dose)
Table 65. APAC Calming Aids for Dogs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Calming Aids for Dogs Sales Forecast by Country (2026-2031) & (K Dose)
Table 67. Europe Calming Aids for Dogs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Calming Aids for Dogs Sales Forecast by Country (2026-2031) & (K Dose)
Table 69. Middle East & Africa Calming Aids for Dogs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Calming Aids for Dogs Sales Forecast by Type (2026-2031) & (K Dose)
Table 71. Global Calming Aids for Dogs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Calming Aids for Dogs Sales Forecast by Application (2026-2031) & (K Dose)
Table 73. Global Calming Aids for Dogs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. VetriScience Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 75. VetriScience Calming Aids for Dogs Product Portfolios and Specifications
Table 76. VetriScience Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 77. VetriScience Main Business
Table 78. VetriScience Latest Developments
Table 79. H&H Group Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 80. H&H Group Calming Aids for Dogs Product Portfolios and Specifications
Table 81. H&H Group Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 82. H&H Group Main Business
Table 83. H&H Group Latest Developments
Table 84. Vetoquinol Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 85. Vetoquinol Calming Aids for Dogs Product Portfolios and Specifications
Table 86. Vetoquinol Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 87. Vetoquinol Main Business
Table 88. Vetoquinol Latest Developments
Table 89. ThunderEase Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 90. ThunderEase Calming Aids for Dogs Product Portfolios and Specifications
Table 91. ThunderEase Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 92. ThunderEase Main Business
Table 93. ThunderEase Latest Developments
Table 94. Maxxidog Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 95. Maxxidog Calming Aids for Dogs Product Portfolios and Specifications
Table 96. Maxxidog Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 97. Maxxidog Main Business
Table 98. Maxxidog Latest Developments
Table 99. Heavenly Hounds Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 100. Heavenly Hounds Calming Aids for Dogs Product Portfolios and Specifications
Table 101. Heavenly Hounds Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 102. Heavenly Hounds Main Business
Table 103. Heavenly Hounds Latest Developments
Table 104. ElleVet Sciences Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 105. ElleVet Sciences Calming Aids for Dogs Product Portfolios and Specifications
Table 106. ElleVet Sciences Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 107. ElleVet Sciences Main Business
Table 108. ElleVet Sciences Latest Developments
Table 109. Wild One Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 110. Wild One Calming Aids for Dogs Product Portfolios and Specifications
Table 111. Wild One Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 112. Wild One Main Business
Table 113. Wild One Latest Developments
Table 114. FOMO Bones Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 115. FOMO Bones Calming Aids for Dogs Product Portfolios and Specifications
Table 116. FOMO Bones Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 117. FOMO Bones Main Business
Table 118. FOMO Bones Latest Developments
Table 119. Ark Naturals Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 120. Ark Naturals Calming Aids for Dogs Product Portfolios and Specifications
Table 121. Ark Naturals Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 122. Ark Naturals Main Business
Table 123. Ark Naturals Latest Developments
Table 124. Purina Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 125. Purina Calming Aids for Dogs Product Portfolios and Specifications
Table 126. Purina Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 127. Purina Main Business
Table 128. Purina Latest Developments
Table 129. Kradle Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 130. Kradle Calming Aids for Dogs Product Portfolios and Specifications
Table 131. Kradle Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 132. Kradle Main Business
Table 133. Kradle Latest Developments
Table 134. Zoetis Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 135. Zoetis Calming Aids for Dogs Product Portfolios and Specifications
Table 136. Zoetis Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 137. Zoetis Main Business
Table 138. Zoetis Latest Developments
Table 139. Pet Remedy Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 140. Pet Remedy Calming Aids for Dogs Product Portfolios and Specifications
Table 141. Pet Remedy Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 142. Pet Remedy Main Business
Table 143. Pet Remedy Latest Developments
Table 144. Ceva Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 145. Ceva Calming Aids for Dogs Product Portfolios and Specifications
Table 146. Ceva Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 147. Ceva Main Business
Table 148. Ceva Latest Developments
Table 149. Adaptil Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 150. Adaptil Calming Aids for Dogs Product Portfolios and Specifications
Table 151. Adaptil Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 152. Adaptil Main Business
Table 153. Adaptil Latest Developments
Table 154. Primo Pup Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 155. Primo Pup Calming Aids for Dogs Product Portfolios and Specifications
Table 156. Primo Pup Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 157. Primo Pup Main Business
Table 158. Primo Pup Latest Developments
Table 159. Penelope's Bloom Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 160. Penelope's Bloom Calming Aids for Dogs Product Portfolios and Specifications
Table 161. Penelope's Bloom Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 162. Penelope's Bloom Main Business
Table 163. Penelope's Bloom Latest Developments
Table 164. Extract Labs Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 165. Extract Labs Calming Aids for Dogs Product Portfolios and Specifications
Table 166. Extract Labs Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 167. Extract Labs Main Business
Table 168. Extract Labs Latest Developments
Table 169. Koi CBD Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 170. Koi CBD Calming Aids for Dogs Product Portfolios and Specifications
Table 171. Koi CBD Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 172. Koi CBD Main Business
Table 173. Koi CBD Latest Developments
Table 174. Elanco Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 175. Elanco Calming Aids for Dogs Product Portfolios and Specifications
Table 176. Elanco Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 177. Elanco Main Business
Table 178. Elanco Latest Developments
Table 179. Zatural Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 180. Zatural Calming Aids for Dogs Product Portfolios and Specifications
Table 181. Zatural Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 182. Zatural Main Business
Table 183. Zatural Latest Developments
Table 184. The Anxious Pet Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 185. The Anxious Pet Calming Aids for Dogs Product Portfolios and Specifications
Table 186. The Anxious Pet Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 187. The Anxious Pet Main Business
Table 188. The Anxious Pet Latest Developments
Table 189. This Dog's Life Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 190. This Dog's Life Calming Aids for Dogs Product Portfolios and Specifications
Table 191. This Dog's Life Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 192. This Dog's Life Main Business
Table 193. This Dog's Life Latest Developments
Table 194. NaturVet Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 195. NaturVet Calming Aids for Dogs Product Portfolios and Specifications
Table 196. NaturVet Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 197. NaturVet Main Business
Table 198. NaturVet Latest Developments
Table 199. King Kanine Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 200. King Kanine Calming Aids for Dogs Product Portfolios and Specifications
Table 201. King Kanine Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 202. King Kanine Main Business
Table 203. King Kanine Latest Developments
Table 204. Dr. Harvey’s Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 205. Dr. Harvey’s Calming Aids for Dogs Product Portfolios and Specifications
Table 206. Dr. Harvey’s Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 207. Dr. Harvey’s Main Business
Table 208. Dr. Harvey’s Latest Developments
Table 209. PetHonesty Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 210. PetHonesty Calming Aids for Dogs Product Portfolios and Specifications
Table 211. PetHonesty Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 212. PetHonesty Main Business
Table 213. PetHonesty Latest Developments
Table 214. Merck Animal Health Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 215. Merck Animal Health Calming Aids for Dogs Product Portfolios and Specifications
Table 216. Merck Animal Health Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 217. Merck Animal Health Main Business
Table 218. Merck Animal Health Latest Developments
Table 219. Boehringer Ingelheim Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 220. Boehringer Ingelheim Calming Aids for Dogs Product Portfolios and Specifications
Table 221. Boehringer Ingelheim Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 222. Boehringer Ingelheim Main Business
Table 223. Boehringer Ingelheim Latest Developments
Table 224. Shangrao Chunyu Technology Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 225. Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolios and Specifications
Table 226. Shangrao Chunyu Technology Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 227. Shangrao Chunyu Technology Main Business
Table 228. Shangrao Chunyu Technology Latest Developments
Table 229. Shandong Youmi Le Health Technology Basic Information, Calming Aids for Dogs Manufacturing Base, Sales Area and Its Competitors
Table 230. Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolios and Specifications
Table 231. Shandong Youmi Le Health Technology Calming Aids for Dogs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 232. Shandong Youmi Le Health Technology Main Business
Table 233. Shandong Youmi Le Health Technology Latest Developments


List of Figures
Figure 1. Picture of Calming Aids for Dogs
Figure 2. Calming Aids for Dogs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Calming Aids for Dogs Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Calming Aids for Dogs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Calming Aids for Dogs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Calming Aids for Dogs Sales Market Share by Country/Region (2024)
Figure 10. Calming Aids for Dogs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Calming Supplements
Figure 12. Product Picture of Pheromone Sprays
Figure 13. Product Picture of Calming Collars
Figure 14. Product Picture of Anxiety Vests
Figure 15. Global Calming Aids for Dogs Sales Market Share by Type in 2025
Figure 16. Global Calming Aids for Dogs Revenue Market Share by Type (2020-2025)
Figure 17. Calming Aids for Dogs Consumed in Household
Figure 18. Global Calming Aids for Dogs Market: Household (2020-2025) & (K Dose)
Figure 19. Calming Aids for Dogs Consumed in Pet Hospitals and Clinics
Figure 20. Global Calming Aids for Dogs Market: Pet Hospitals and Clinics (2020-2025) & (K Dose)
Figure 21. Calming Aids for Dogs Consumed in Pet Shop
Figure 22. Global Calming Aids for Dogs Market: Pet Shop (2020-2025) & (K Dose)
Figure 23. Calming Aids for Dogs Consumed in Others
Figure 24. Global Calming Aids for Dogs Market: Others (2020-2025) & (K Dose)
Figure 25. Global Calming Aids for Dogs Sale Market Share by Application (2024)
Figure 26. Global Calming Aids for Dogs Revenue Market Share by Application in 2025
Figure 27. Calming Aids for Dogs Sales by Company in 2025 (K Dose)
Figure 28. Global Calming Aids for Dogs Sales Market Share by Company in 2025
Figure 29. Calming Aids for Dogs Revenue by Company in 2025 ($ millions)
Figure 30. Global Calming Aids for Dogs Revenue Market Share by Company in 2025
Figure 31. Global Calming Aids for Dogs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Calming Aids for Dogs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Calming Aids for Dogs Sales 2020-2025 (K Dose)
Figure 34. Americas Calming Aids for Dogs Revenue 2020-2025 ($ millions)
Figure 35. APAC Calming Aids for Dogs Sales 2020-2025 (K Dose)
Figure 36. APAC Calming Aids for Dogs Revenue 2020-2025 ($ millions)
Figure 37. Europe Calming Aids for Dogs Sales 2020-2025 (K Dose)
Figure 38. Europe Calming Aids for Dogs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Calming Aids for Dogs Sales 2020-2025 (K Dose)
Figure 40. Middle East & Africa Calming Aids for Dogs Revenue 2020-2025 ($ millions)
Figure 41. Americas Calming Aids for Dogs Sales Market Share by Country in 2025
Figure 42. Americas Calming Aids for Dogs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Figure 44. Americas Calming Aids for Dogs Sales Market Share by Application (2020-2025)
Figure 45. United States Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Calming Aids for Dogs Sales Market Share by Region in 2025
Figure 50. APAC Calming Aids for Dogs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Figure 52. APAC Calming Aids for Dogs Sales Market Share by Application (2020-2025)
Figure 53. China Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Calming Aids for Dogs Sales Market Share by Country in 2025
Figure 61. Europe Calming Aids for Dogs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Figure 63. Europe Calming Aids for Dogs Sales Market Share by Application (2020-2025)
Figure 64. Germany Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 65. France Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Calming Aids for Dogs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Calming Aids for Dogs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Calming Aids for Dogs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Calming Aids for Dogs in 2025
Figure 78. Manufacturing Process Analysis of Calming Aids for Dogs
Figure 79. Industry Chain Structure of Calming Aids for Dogs
Figure 80. Channels of Distribution
Figure 81. Global Calming Aids for Dogs Sales Market Forecast by Region (2026-2031)
Figure 82. Global Calming Aids for Dogs Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Calming Aids for Dogs Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Calming Aids for Dogs Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Calming Aids for Dogs Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Calming Aids for Dogs Revenue Market Share Forecast by Application (2026-2031)